Record Display for the EPA National Library Catalog
RECORD NUMBER: 409 OF 886| Main Title | Evaluation of the potential carcinogenicity of N-Nitrosopiperidine (100-75-4) / | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORP Author | Syracuse Research Corp., NY. ;Environmental Monitoring and Services, Inc., Washington, DC.;Environmental Protection Agency, Washington, DC. Office of Health and Environmental Assessment. | |||||||||||
| Publisher | U.S. Environmental Protection Agency, Office of Emergency and Remedial Response ; | |||||||||||
| Year Published | 1988 | |||||||||||
| Report Number | EPA-68-03-3112; EPA-68-03-3182; EPA/600/8-91/167; OHEA-C-073-155 | |||||||||||
| Stock Number | PB93-196517 | |||||||||||
| Subjects | N-Nitrosopiperidine--Carcinogenicity | |||||||||||
| Additional Subjects | Nitroso compounds ; Piperidines ; Toxicity ; Risk assessment ; Public health ; Exposure ; Hazardous materials ; Neoplasms ; Tolerances(Physiology) ; Carcinogenicity ; Dose-response relationships ; CAS: 100-75-4 | |||||||||||
| Holdings |
|
|||||||||||
| Collation | 16 pages ; 28 cm | |||||||||||
| Abstract | N-Nitrosopiperidine is a probable human carcinogen, classified as weight-of-evidence Group B2 under the EPA Guidelines for Carcinogen Risk Assessment. Evidence on potential carcinogenicity from animal studies is 'Sufficient', and the evidence from human studies is 'No Data' since there are no human studies. The potency factor (F) for N-nitrosopiperidine is estimated to be 37.5 (mg/kg/day)-1, placing it in potency group 2 according to the CAG's methodology for evaluating potential carcinogens. Combining the weight-of-evidence group and the potency group, N-nitrosopiperidine is assigned a 'MEDIUM' hazard ranking. |
|||||||||||
| Notes | Cover title. "June 1988." Includes bibliographical references. Microfiche. |